Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes.
InterMune Reports MOU On Consolidated Delaware Action On Takeover By Roche
Brodsky & Smith, LLC Announces Investigation Of Taminco Sale To Eastman Chemical
Oracle Corp. (ORCL) reported first quarter adjusted EPS of $0.62 after the bell Thursday, up from $0.59 in the prior year period. Analysts expected EPS of $0.64.
The company also announced that its Chief Executive Officer, Larry Ellison, will be leaving his position. Ellison has been elected Executive...